White House preparing executive order requiring certain essential drugs be made in U.S., sources say
Editor’s note: We’ve been pushing for this for a while. Let’s hope Friday is indeed the day. The White House is preparing an executive order
What does COVID stimulus bill – CARES Act – do for small CPA member companies?
By David Morse, Tax Policy Director The president just signed the CARES Act after a week of negotiations in the Senate, and a Congressional kerfuffle
Ventilator Blues
Excerpt: America’s small businesses, our machinists, die-casters, plastic injection molders, electronics parts suppliers, and others are eager to get to work providing the medical equipment the
Update on Administration Efforts on COVID-19 | March 23, 2020
Editor’s note: Here are the recent actions from the Trump administration on COVID. Note especially the FDA actions relaxing certain rules for ventilators and other
Reshoring US Pharmaceutical Production Would Create 800K Jobs
Health, Security, Economic Benefits from Reshoring By Steven L. Byers, PhD and Jeff Ferry With the spreading coronavirus pandemic, Americans are becoming increasingly aware of
China’s dominance of the pharma supply chain is highly dangerous to the US
Editor’s note: The silver lining in the coronavirus outbreak is that calls for reshoring medical supplies and devices is becoming very strong. Which will help
China RX Exposes Risks of Dependence on China for Medicines
Excerpt: How did the pharmaceutical industry start sourcing pharmaceuticals in China? After her presentation at the Made in America trade show last month, I met Rosemary
Amazon’s Heavy Recruitment of Chinese Sellers Puts Consumers at Risk
Editor’s note. Dangerous Chinese products brought to you by Amazon. Enabled by section 321 de minimis rule that allows higher value tariff free imports than
Carcinogens Have Infiltrated the Generic Drug Supply in the U.S.
Editor’s note: Pharmaceutical ingredients from China are uninspected, contaminated with carcinogens, and often simply ineffective. We need to rebuild this supply chain in the US.
NAFTA 2.0: IS THE SOE CHAPTER A RED HERRING?
Excerpt: “China’s authoritarian government, size, and anticompetitive intent are more problematic than the ownership structure of the companies in question. The government can fund them, without
